Wednesday, May 31, 2017 8:16:35 PM
Johnson & Johnson has 2.69 billion shares outstanding @ $128 PPS
Merck has 2.72 billion shares outstanding @ $65 PPS
Bristol-Myers Squibb has 1.64 billion shares outstanding @ $53 PPS
Eli Lilly has 1.1 billion shares outstanding @ $79 PPS
Abbott Laboratories has 1.7 billion shares outstanding @ $45 PPS
Theralase Technologies has 124 million shares outstanding @ $.26 PPS
Its good to have data to compare too and our contempories are doing just fine with outstanding share counts anywhere from 10 to 47 times ours. We have quite a way to go before I start to worry about dilution.
I think Roger has been prudent with investor resources and am pleased with his financial stewardship of my investment. Getting off this exchange would be good and I'm looking forward to the early meeting this year...my guess is things have changed and more opportunity now exists now than ever before.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM